Bioanalytical Systems, Inc. (BASI) financial statements (2020 and earlier)

Company profile

Business Address 2701 KENT AVE
WEST LAFAYETT, IN 47906-1382
State of Incorp. IN
Fiscal Year End September 30
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1110001
Cash and cash equivalents1110001
Receivables9743233
Inventory, net of allowances, customer advances and progress billings1111112
Inventory1111112
Prepaid expense2111111
Other undisclosed current assets2211111
Total current assets:151285577
Noncurrent Assets
Finance lease, right-of-use asset5 
Operating lease, right-of-use asset5 
Nontrade receivables00000  
Property, plant and equipment27231715161616
Intangible assets, net (including goodwill)9660011
Goodwill7430011
Intangible assets, net (excluding goodwill)333    
Regulated entity, other noncurrent assets    000
Deferred income tax assets 0
Other noncurrent assets0000000
Other undisclosed noncurrent assets  0    
Total noncurrent assets:46302315161717
TOTAL ASSETS:61423120212424
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9853455
Accounts payable6532333
Accrued liabilities3321122
Taxes payable   0000
Deferred revenue 7
Debt7110411
Derivative instruments and hedges, liabilities    001
Restructuring reserve00111  
Customer advances and deposits3333
Other undisclosed current liabilities1225 100
Total current liabilities:28171281399
Noncurrent Liabilities
Long-term debt and lease obligation231494045
Long-term debt, excluding current maturities191494 44
Finance lease, liability0 
Capital lease obligations00000
Operating lease, liability4 
Liabilities, other than long-term debt0    00
Deferred income tax liabilities0 
Derivative instruments and hedges, liabilities     00
Other undisclosed noncurrent liabilities 0     
Total noncurrent liabilities:231494045
Total liabilities:51312012141314
Stockholders' equity
Stockholders' equity attributable to parent101111871110
Preferred stock0001111
Common stock3332222
Additional paid in capital26252521212121
Accumulated other comprehensive income (loss)    (0)00
Accumulated deficit(19)(17)(16)(16)(17)(14)(15)
Total stockholders' equity:101111871110
TOTAL LIABILITIES AND EQUITY:61423120212424

Income statement (P&L) ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Revenues48442624202325
Revenue, net24202325
Cost of revenue
(Cost of Goods and Services Sold)
(34)(31)(18)(17)(16)(15)(17)
Gross profit:141388478
Operating expenses(15)(13)(8)(6)(7)(7)(8)
Operating income (loss):(1)(0)01(3)10
Nonoperating income0000000
Gain on contract termination     0 
Other nonoperating income0000000
Interest and debt expense(1)(1)(0)(0)(0)(0)(1)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes    00(1)
Income (loss) from continuing operations before income taxes:(2)(1)(0)1(3)1(1)
Income tax expense (benefit)(0)(0)0(0)0(0)(0)
Income (loss) before gain (loss) on sale of properties:(2)(1)(0)1(3)1(1)
Other undisclosed net loss  (0)    
Net income (loss):(2)(1)(0)1(3)1(1)
Other undisclosed net income attributable to parent  0    
Net income (loss) available to common stockholders, basic:(2)(1)(0)1(3)1(1)
Dilutive securities, effect on basic earnings per share     (0) 
Net income (loss) available to common stockholders, diluted:(2)(1)(0)1(3)1(1)

Comprehensive Income ($ in millions)

12/31/2019
TTM
9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
Net income (loss):(2)(1)(0)1(3)1(1)
Comprehensive income (loss):(2)(1)(0)1(3)1(1)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  00(0)0(0)
Comprehensive income (loss), net of tax, attributable to parent:(2)(1)(0)1(3)1(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: